Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 5Prostatic Neoplasms 4Multiple Myeloma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic Syndromes 1Metastatic HER2-positive Breast Cancer With Brain Metastasis 1Leukemia, Biphenotypic, Acute 1Leukemia 1Insulinoma 1Hyperinsulinism 1Fallopian Tube Neoplasms 1Desmoplastic Small Round Cell Tumor 1Congenital Hyperinsulinism 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Burkitt Lymphoma 1Adenocarcinoma 1

Interventions

Cisplatin 5nimotuzumab 2X-Rays 2Radiotherapy 2Magnetic Resonance Spectroscopy 2trifluridine tipiracil drug combination 1sargramostim 1palladium-bacteriopheophorbide 1padeliporfin 1imgatuzumab 1galactomannan 1futuximab 1fluoromisonidazole 1capmatinib 1cabozantinib 1Tomography, Optical Coherence 1Standard of Care 1Specimen Handling 1Ramucirumab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Practice Guidelines as Topic 1Platinum 1Nivolumab 1N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1Mitomycin 1LMB-100 1Ipilimumab 1Interviews as Topic 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma × Injections × Clear all
NCT01125449 2025-05-18

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

Situs Cancer Research Center

Phase 2 Withdrawn
Plasma cellSarcoma

Adenocarcinoma, Carcinoma, Multiple Myeloma, Sarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡